Skip to content
★ Sign in to follow
MD

Mark D. Reeth

Salix Pharmaceuticals Ltd
Total declarations
19
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€628k

Latest filing published 03 May 2012 for SALIX PHARMACEUTICALS LTD, €37k.

Insider track record

Disclosed buys
0
Disclosed sells
7
Signal history

No signal scores available.

Mark D. Reeth: trading record in brief

All filings by Mark D. Reeth on record concern Salix Pharmaceuticals Ltd. In total, 19 filings cover trades dated from 14 May 2007 to 1 May 2012.

Sales make up the whole of the open-market record (7 sales, €628k). Outside the open market, there are 12 share grants. So far in 2012, the count stands at no purchases and 1 sale.

On 3 May 2012 came the latest disclosure, an open-market sale for €37k in Salix Pharmaceuticals Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Mark D. Reeth

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations19 total

19 of 19 declarations